Responding to Correspondence on "Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes".

Leslie Citrome, Marko A Mychaskiw, Alma Cortez, Mark Opler, Liza Sopina, Sameer Kotak

Abstract readLetter

In one paragraph

Article in Innovations in clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leslie CitromeDr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences, New York Medical College in Valhalla, New York.

Marko A MychaskiwDr. Mychaskiw is Senior Director- Global Health Economics and Outcomes Research and Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc. in West Chester, Pennsylvania.

Alma CortezMs. Cortez is Director-Global Health Economics and Outcomes Research, Teva Branded Pharmaceutical Products R&D, Inc. in West Chester, Pennsylvania.

Mark OplerDr. Opler is Chief Research Officer, WCG MedAvante-ProPhase Inc. in New York, New York.

Liza SopinaDr. Sopina is an independent consultant in Odense, Denmark.

Sameer KotakMr. Kotak is with Yorker Health in Bridgewater, New Jersey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38938536

PMCPMC11208010

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.